查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
猪疫苗市场规模、份额、趋势分析报告，按产品（重组、灭活）、按类型（伪狂犬病、猪圆环病毒 2 型）、按地区、按细分市场，2022-2030 年
市场调查报告书
商品编码
1147476

猪疫苗市场规模、份额、趋势分析报告，按产品（重组、灭活）、按类型（伪狂犬病、猪圆环病毒 2 型）、按地区、按细分市场，2022-2030 年

Swine Vaccines Market Size, Share & Trends Analysis Report, By Product (Recombinant, Inactivated), By Type (Pseudorabies, Porcine Circovirus Type 2), By Region, and Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

猪疫苗市场的增长和趋势

根据 Grandview Research 的一份新报告，到 2030 年，全球猪疫苗市场预计将达到 23 亿美元。从 2022 年到 2030 年，该市场预计将实现 4.9% 的复合年增长率。猪病流行率和发病率的上升、对人畜共患疾病的关注增加以及养猪场生物安全措施的增加是推动市场增长的一些主要因素。此外，政府和动物保健组织为传播疾病意识和支持疫苗接种所做的努力进一步推动了预测期内的市场增长。

COVID-19 大流行直接或间接影响了主要参与者的猪疫苗业务运营，最初导致财务业绩不佳。由于各种生产和供应链瓶颈导致大流行的影响，必要的原材料和活性成分的供应被推迟，某些研发活动被推迟。但与此同时，多个地区爆发非洲猪瘟疫情，对猪用疫苗生产企业提出了巨大需求。 2020 年，OIE 报告称亚洲爆发了 9,928 起 ASF，其次是欧洲爆发了 4,271 起。鑑于这种情况，政府因此藉机放鬆管制并支持猪疫苗的分销并重组公司的增长。

此外，在农业和兽医领域，全球范围内对抗生素耐药性的担忧日益加剧。因此，一些国家已禁止在畜牧业中使用抗生素，包括预防性治疗。法律强制养猪场采用非抗生素疾病预防方法，例如接种疫苗。此外，主要参与者为开发先进产品以进行更好的诊断而进行的投资可能会推动市场增长。例如，2020 年 5 月，Indian Immunologicals Ltd. 推出了品牌名为“Raksha Class”的经典猪瘟疫苗，这是一种基于与印度兽医研究所 Bareilly 合作开发的专有细胞培养技术的疫苗。

市场参与者正在实施各种战略举措，例如收购、合併、合作伙伴关係和产品发布，以保持市场竞争力。例如，2022 年 3 月，Ceva 推出了猪疫苗，这是一种含有七种抗原的疫苗，用于治疗新生儿腹泻。

猪疫苗市场报告要点

由于主要养猪国家的大流行，2021 年 PRRS（猪繁殖与呼吸综合征）细分市场在该类型细分市场中的销售额份额最大。该病在美国流行了30多年，在养猪大国中国也流行了20多年。

按产品划分，灭活疫苗细分市场将在 2021 年占据最大的市场份额。这些疫苗比减毒活疫苗更稳定，可以为猪提供更好的免疫力。它还可以防止病原体复製，因此不存在毒力再次出现的风险。

亚太地区预计将在 2021 年占据最大的市场份额，并以最快的复合年增长率增长。这一显着份额主要是由于中国等主要生猪生产国的存在、庞大的肉类消费人口，以及对控制当前亚洲猪群疾病爆发的疫苗的广泛需求。

这个市场与 Zoetis、Merck、Ceva、Boehringer Ingelheim International GmbH、Elanco 和 Virbac 等大公司竞争激烈。公司采取的各种战略举措，如收购、联盟、产品发布和合作伙伴关係，为市场的增长做出了重大贡献。

内容

第 1 章调查方法及范围

  • 市场细分和范围
    • 细分范围
    • 区域范围
  • 调查方法
  • 资讯采购
    • 购买的数据库：
    • GVR 内部数据库
    • 次要资讯
    • 初步调查
    • 初步调查的详细资讯
  • 资讯和数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细资讯
    • 商品流分析
      • 自下而上的市场预测
      • 自上而下的市场预测
    • 全球市场：CAGR 计算
  • 次要信息列表

第 2 章执行摘要

  • 猪疫苗市场展望
    • 细分市场展望
    • 区域展望
    • 竞争前景
  • 2021 年猪疫苗市场概况

第 3 章猪疫苗市场变量、趋势和范围

  • 市场系列展望
    • 母市场分析
    • 补充市场分析
  • 渗透率和增长前景图，产品类型，2021 年
  • 猪疫苗市场动态
    • 市场促进因素分析
      • 对人畜共患疾病的日益关注和加强生物安全
      • 疫苗可替代抗生素
      • 技术进步
      • 监管义务
    • 市场抑制因素分析
      • 产品独占期短
      • 宗教和文化限制
      • 禁止供应生猪和猪肉产品
  • 行业分析
    • 波特的分析
      • 新进入者的威胁：中低
      • 替代品的威胁：中到高
      • 买家的议价能力：中等
      • 供应商的议价能力：低
      • 竞争对手之间的敌意：高
    • PESTEL 分析
      • 政治和法律格局
      • 经济的
      • 社交
      • 技术
      • 环境
  • 监管框架
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 世界其他地方
  • 产品管道分析

第 4 章猪疫苗市场：Covid-19 影响分析

  • Covid-19 影响分析

第 5 章按产品分类的估计和趋势分析，2017-2030（百万美元）

  • 2017-2030 年产品差异分析（百万美元）
  • 2021 年和 2030 年猪疫苗市场份额分析
    • 减毒活疫苗
    • 灭活□□疫苗
    • 亚单位疫苗
    • DNA疫苗
    • 重组疫苗

第 6 章按类型估算和趋势分析，2017-2030（百万美元）

  • 2017-2030 年类型变化分析（百万美元）
  • 2021 年和 2030 年猪疫苗市场份额分析
    • 猪流感
    • 不丹热
    • 猪细小病毒
    • 2 型猪圆环病毒
    • 猪肺炎支原体
    • 胸膜肺炎放线桿菌
    • 蓝耳病
    • 手足口病
    • 伪狂犬病
    • 猪流行性腹泻
    • 其他

第 7 章2017 年至 2030 年各地区的估计和趋势（百万美元）

  • 区域市场概况
  • 2021 年和 2030 年区域市场份额分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 法国
    • 德国
    • 西班牙
    • 意大利
    • 英国
  • 亚太地区
    • 印度
    • 中国
    • 日本
    • 澳大利亚
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多边环境协定
    • 南非
    • 沙特阿拉伯

第 8 章竞争格局

  • 市场参与分类
  • 上市公司
    • 公司市场分析
    • 热图分析
  • 私人公司
    • 主要公司名单

第 9 章猪疫苗市场 - 公司概况

  • Merck &Co., Inc.
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Ceva
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Zoetis
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Boehringer Ingelheim International GmbH
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Elanco
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Indian Immunologicals Ltd.
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Biogenesis Bago
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Phibro Animal Health Corporation
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • KM Biologics（Meiji Holdings Co., Ltd）
    • 公司简介
    • 财务业绩
    • 产品基准
  • HIPRA
    • 公司简介
    • 产品基准
    • 战略举措
  • Virbac
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
Product Code: GVR-4-68039-728-0

Swine Vaccines Market Growth & Trends:

The global swine vaccines market size is expected to reach USD 2.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness a lucrative CAGR of 4.9% from 2022 to 2030. The increasing prevalence and incidence of swine diseases, rising concerns over zoonoses, and strengthening biosecurity measures among swine farms are some of the major factors augmenting the market growth. In addition, the initiatives taken by government and animal healthcare organizations in spreading disease awareness and supporting vaccination drives are further propelling the market growth during the projected period.

The Covid-19 pandemic has directly or indirectly impacted the key player's swine vaccine business operations and resulted in declined financial performance during the initial time. The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities. However, the simultaneously reported African swine fever outbreaks in several regions pressured the swine vaccine manufacturers with a large demand. In 2020, the OIE reported 9,928 ASF outbreaks in Asia, followed by 4,271 outbreaks in Europe. Hence, considering the situation, the government supported the distribution of swine vaccines with ease of restrictions, which afforded opportunities to rebuild the company's growth.

In addition, the global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Thus, several countries have banned the use of antibiotics for livestock farming, including preventive treatment procedures. This act has compelled swine farms to adopt antibiotic-free disease preventive approaches such as vaccination. Furthermore, growing investments by key players to develop advanced products for better diagnosis are likely to propel market growth. For instance, in May 2020, Indian Immunologicals Ltd. introduced the Classical Swine Fever vaccine under the brand name 'Raksha Class', a unique cell culture technology-based vaccine developed in cooperation with the Indian Veterinary Research Institute, Bareilly.

Key players in the market are implementing various strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, among others to maintain a competitive edge in the market. For instance, In March 2022, Ceva launched the sow vaccine, a vaccine containing seven antigens used to treat neonatal diarrhea.

Swine Vaccines Market Report Highlights:

  • The PRRS (Porcine Reproductive and Respiratory Syndrome) segment accounted for the largest revenue share in 2021 by type segment owing to its large prevalence in major swine-raising countries. The disease has been considered an epidemic for over 30 years in the U.S. and more than 20 years in China, the leading swine industry
  • By product, the inactivated vaccines segment held the largest market share in 2021. These vaccines are more stable than live attenuated vaccines and can provide swine with better immunization. They prevent pathogen replication and therefore do not possess the risk of virulence reversion
  • Asia Pacific accounted for the largest market share in 2021 and is expected to grow at the fastest CAGR. Key factors contributing to this notable share include the presence of leading swine production countries such as China coupled with a large meat-consuming population and wide requirement for vaccines to curb current rising disease outbreaks among Asian swine herds
  • The market is fairly competitive owing to the presence of major players such as Zoetis, Merck, Ceva, Boehringer Ingelheim International GmbH, Elanco, and Virbac among others. The various strategic initiatives implemented by companies such as acquisitions, collaborations, product launches, and partnerships are greatly contributing to the growth of the market

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information/Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Bottom - Up Market Estimation
      • 1.6.1.2 Top - Down Market Estimation
    • 1.6.2 Global Market: Cagr Calculation
  • 1.7 List Of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Swine Vaccines Market Outlook
    • 2.1.1 Segment Outlook
    • 2.1.2 Regional Outlook
    • 2.1.3 Competitive Outlook
  • 2.2 Swine Vaccines Market Snapshot, 2021

Chapter 3 Swine Vaccines Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Penetration And Growth Prospect Mapping, By Product Type, 2021
  • 3.3 Swine Vaccines Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Rising Concern About Zoonoses & Strengthening Biosecurity
      • 3.3.1.2 Vaccines Act As An Alternative To Antibiotics
      • 3.3.1.3 Technological Advancements
      • 3.3.1.4 Regulatory Mandates
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Short Product Exclusivity Period
      • 3.3.2.2 Religious And Cultural Restrictions
      • 3.3.2.3 Supply Bans On Live Pigs And Pork Products
  • 3.4 Industry Analysis
    • 3.4.1 Porter's Analysis
      • 3.4.1.1 Threat Of New Entrants: Low - Moderate
      • 3.4.1.2 Threat Of Substitutes: Moderate To High
      • 3.4.1.3 Bargaining Power Of Buyers: Moderate
      • 3.4.1.4 Bargaining Power Of Suppliers: Low
      • 3.4.1.5 Competitive Rivalry: High
    • 3.4.2 Pestel Analysis
      • 3.4.2.1 Political & Legal Landscape
      • 3.4.2.2 Economic
      • 3.4.2.3 Social
      • 3.4.2.4 Technological
      • 3.4.2.5 Environmental
  • 3.5 Regulatory Framework
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Apac
    • 3.5.4 Latam
    • 3.5.5 Rest Of The World
  • 3.6 Product Pipeline Analysis

Chapter 4 Swine Vaccines Market: Covid - 19 Impact Analysis

  • 4.1 Covid - 19 Impact Analysis

Chapter 5 Product Estimates & Trend Analysis, 2017 - 2030 (USD Million)

  • 5.1 Product Movement Analysis, 2017 - 2030 (USD Million)
  • 5.2 Swine Vaccines Market Share Analysis, 2021 & 2030
    • 5.2.1 Attenuated Live Vaccines
      • 5.2.1.1 Attenuated Live Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 5.2.2 Inactivated Vaccines
      • 5.2.2.1 Inactivated Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 5.2.3 Subunit Vaccines
      • 5.2.3.1 Subunit Vaccines Market estimates and forecasts, 2017 - 2030 (USD Million)
    • 5.2.4 Dna Vaccines
      • 5.2.4.1 Dna Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 5.2.5 Recombinant Vaccines
      • 5.2.5.1 Recombinant Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 6 Type Estimates & Trend Analysis, 2017 - 2030 (USD Million)

  • 6.1 Type Movement Analysis, 2017 - 2030 (USD Million)
  • 6.2 Swine Vaccines Market Share Analysis, 2021 & 2030
    • 6.2.1 Swine Influenza
      • 6.2.1.1 Swine Influenza Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.2 Classical Swine Fever
      • 6.2.2.1 Classical Swine Fever Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.3 Porcine Parvovirus
      • 6.2.3.1 Porcine Parvovirus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.4 Porcine Circovirus Type 2
      • 6.2.4.1 Porcine Circovirus Type 2 Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.5 M.Hyo
      • 6.2.5.1 M.Hyo Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.6 Actinobacillus Pleuropneumonia
      • 6.2.6.1 Actinobacillus Pleuropneumonia Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.7 PRRS
      • 6.2.7.1 PRRS Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.8 Foot & Mouth Disease
      • 6.2.8.1 Foot & Mouth Disease Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.9 Pseudorabies
      • 6.2.9.1 Pseudorabies Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.10 Porcine Epidemic Diarrhea
      • 6.2.10.1 Pedv Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.11 Others
      • 6.2.11.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 7 Regional Estimates & Trend Analysis, 2017 - 2030 (USD Million)

  • 7.1 Regional Market Snapshot
  • 7.2 Regional Market Share Analysis, 2021 & 2030
  • 7.3 North America
    • 7.3.1 North America Swine Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 7.3.2 U.S.
      • 7.3.2.1 U.S. Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.3.3 Canada
      • 7.3.3.1 Canada Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
  • 7.4 Europe
    • 7.4.1 Europe Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.4.2 France
      • 7.4.2.1 France Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.4.3 Germany
      • 7.4.3.1 Germany Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.4.4 Spain
      • 7.4.4.1 Spain Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.4.5 Italy
      • 7.4.5.1 Italy Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.4.6 U.K.
      • 7.4.6.1 UK Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
  • 7.5 Asia Pacific
    • 7.5.1 Asia Pacific Swine Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 7.5.2 India
      • 7.5.2.1 India Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.5.3 China
      • 7.5.3.1 China Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.5.4 Japan
      • 7.5.4.1 Japan Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.5.5 Australia
      • 7.5.5.1 Australia Swine Vaccines Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 7.5.6 South Korea
      • 7.5.6.1 South Korea Swine Vaccines Market Estimates and Forecasts, 2017 - 2030 (USD million)
  • 7.6 Latin America
    • 7.6.1 Latin America Swine Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 7.6.2 Brazil
      • 7.6.2.1 Brazil Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.6.3 Mexico
      • 7.6.3.1 Mexico Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.6.4 Argentina
      • 7.6.4.1 Argentina Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
  • 7.7 MEA
    • 7.7.1 MEA Swine Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 7.7.2 South Africa
      • 7.7.2.1 South Africa Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.7.3 Saudi Arabia
      • 7.7.3.1 Saudi Arabia Swine Vaccines Market estimates and forecasts 2017 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Market Participation Categorization
  • 8.2 Public Companies
    • 8.2.1 Company Market Position Analysis
    • 8.2.2 Heat Map Analysis
  • 8.3 Private Companies
    • 8.3.1 List Of Key Companies

Chapter 9 Swine Vaccines Market - Company Profiles

  • 9.1 Merck & Co., Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Benchmarking
    • 9.1.4 Strategic Initiatives
  • 9.2 Ceva
    • 9.2.1 Company Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Benchmarking
    • 9.2.4 Strategic Initiatives
  • 9.3 Zoetis
    • 9.3.1 Company Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Benchmarking
    • 9.3.4 Strategic Initiatives
  • 9.4 Boehringer Ingelheim International GmbH
    • 9.4.1 Company Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Benchmarking
    • 9.4.4 Strategic Initiatives
  • 9.5 Elanco
    • 9.5.1 Company Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Benchmarking
    • 9.5.4 Strategic Initiatives
  • 9.6 Indian Immunologicals Ltd.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Benchmarking
    • 9.6.4 Strategic Initiatives
  • 9.7 Biogenesis Bago
    • 9.7.1 Company Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Benchmarking
    • 9.7.4 Strategic Initiatives
  • 9.8 Phibro Animal Health Corporation
    • 9.8.1 Company Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Benchmarking
    • 9.8.4 Strategic Initiatives
  • 9.9 KM Biologics (Meiji Holdings Co., Ltd)
    • 9.9.1 Company Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Benchmarking
  • 9.10 HIPRA
    • 9.10.1 Company Overview
    • 9.10.2 Product Benchmarking
    • 9.10.3 Strategic Initiatives
  • 9.11 Virbac
    • 9.11.1 Company Overview
    • 9.11.2 Financial Performance
    • 9.11.3 Product Benchmarking
    • 9.11.4 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 North America Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 3 North America Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 4 U.S. Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 5 U.S. Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 6 Canada Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 7 Canada Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 8 Europe Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 9 Europe Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 10 U.K. Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 11 U.K. Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 12 Germany Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 13 Germany Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 14 France Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 15 France Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 16 Italy Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 17 Italy Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 18 Spain Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 19 Spain Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 20 Asia Pacific Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 21 Asia Pacific Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 22 Japan Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 23 Japan Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 24 China Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 25 China Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 26 India Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 27 India Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 28 Australia Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 29 Australia Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 30 South Korea Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 31 South Korea Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 32 Latin America Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 33 Latin America Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 34 Brazil Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 35 Brazil Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 36 Mexico Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 37 Mexico Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 38 Argentina Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 39 Argentina Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 40 MEA Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 41 MEA Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 42 South Africa Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 43 South Africa Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 44 Saudi Arabia Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 45 Saudi Arabia Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 46 Global Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 47 Global Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)

List of Figures

  • Fig. 1 Swine Vaccines market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value - chain - based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 General methodology for a Commodity flow analysis of Animal Health markets
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Swine Vaccines Market Snapshot (2021, USD Million)
  • Fig. 11 Parent market outlook
  • Fig. 12 Ancillary market outlook
  • Fig. 13 Penetration & growth prospect mapping, by product type, 2021
  • Fig. 14 Swine Vaccines market dynamics analysis
  • Fig. 15 Swine Vaccines market driver analysis
  • Fig. 16 Swine Vaccines market restraint impact
  • Fig. 17 Swine vaccines market: Product movement analysis, 2017 - 2030 (USD Million)
  • Fig. 18 Swine vaccines market share analysis, 2021 & 2030
  • Fig. 19 Attenuated live vaccines market, 2017 - 2030 (USD Million)
  • Fig. 20 Inactivated vaccines market, 2017 - 2030 (USD Million)
  • Fig. 21 Subunit vaccines market, 2017 - 2030 (USD Million)
  • Fig. 22 DNA vaccines market, 2017 - 2030 (USD Million)
  • Fig. 23 Recombinant vaccines market, 2017 - 2030 (USD Million)
  • Fig. 24 Swine vaccines market: Type movement analysis, 2017 - 2030 (USD Million)
  • Fig. 25 Swine vaccines market share analysis, 2021 & 2030
  • Fig. 26 Swine influenza market, 2017 - 2030 (USD Million)
  • Fig. 27 Classical swine fever market, 2017 - 2030 (USD Million)
  • Fig. 28 Porcine parvovirus market, 2017 - 2030 (USD Million)
  • Fig. 29 Porcine circovirus type 2 market, 2017 - 2030 (USD Million)
  • Fig. 30 M.Hyo market, 2017 - 2030 (USD Million)
  • Fig. 31 Actinobacillus pleuropneumonia market, 2017 - 2030 (USD Million)
  • Fig. 32 PRRS market, 2017 - 2030 (USD Million)
  • Fig. 33 Foot & mouth disease market, 2017 - 2030 (USD Million)
  • Fig. 34 Pseudorabies market, 2017 - 2030 (USD Million)
  • Fig. 35 PEDV market, 2017 - 2030 (USD Million)
  • Fig. 36 Others market, 2017 - 2030 (USD Million)
  • Fig. 37 Regional Market Snapshot
  • Fig. 38 Regional Market Share Analysis, 2021 & 2030
  • Fig. 39 Swine Population in North America (Unit in heads)
  • Fig. 40 North America Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 41 U.S. Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 42 Canada Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 43 Europe Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 44 France Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 45 Germany Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 46 Swine population in Spain (Unit in heads)
  • Fig. 47 Spain Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 48 Italy Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 49 U.K. Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 50 Swine population in Asia Pacific (in Millions of heads)
  • Fig. 51 Asia Pacific Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 52 India Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 53 Swine population in China (in Millions of heads)
  • Fig. 54 China Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 55 Japan Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 56 Latin America swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 57 Swine population in Brazil (estimated), 2017 - 2021 (in Millions of heads)
  • Fig. 58 Brazil swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 59 Estimated Swine population in Mexico, 2017 - 2021 (Units in Heads)
  • Fig. 60 Mexico swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 61 Estimated Swine population in Argentina, 2017 - 2021 (Units in Heads)
  • Fig. 62 Argentina swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 63 MEA swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 64 Estimated Swine population in South Africa, 2017 - 2021 (Units in Heads)
  • Fig. 65 South Africa swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 66 Saudi Arabia Swine Vaccines Market, 2017 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia Swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 68 Market participation categorization
  • Fig. 69 Market leaders and innovators
  • Fig. 70 Public company market position analysis